Bath and Body Works (NYSE:BBWI) Exceeds Q2 CY2026 Expectations, but Q3 Guidance Disappoints
Bath & Body Works (BBWI) reported Q2 CY2026 revenue of $1.51B, down 2.3% YoY but beating estimates. EPS of $0.62 also topped forecasts. CEO Daniel Heaf noted sequential improvements in key areas. However, Q3 guidance disappointed, and the stock fell 3.3% post-earnings. The company's same-store sales have declined 1.7% annually over the past two years, raising concerns about organic growth.
How this was made
The 30-second read
Why it matters
Earnings beat may be short‑lived; guidance miss likely drives further downside.
Market read
Earnings release provides fresh data for traders; guidance miss is the primary catalyst.
What to watch
Potential upside from upcoming product innovations and marketplace partnerships.
Background
Bath & Body Works reported Q2 results with revenue down 2.3% YoY, EPS beat, and guidance miss.
Ticker impact
Q2 CY2026 earnings beat revenue estimates but guidance miss caused stock to drop 3.3% to $17.01.
Potential further decline toward $16.50 if guidance remains weak.
Beat on EPS is offset by revenue decline and lower guidance, likely prompting sell‑offs.
Market effects
Consumer discretionary retail faces pressure from slowing same‑store sales.
U.S. retail sector may see modest weakness.
Limited to U.S. consumer discretionary investors.
Counterpoint
Despite guidance miss, the beat on EPS and new store openings could signal a turnaround.
Key entities
- CompanyBath & Body Works
Personal care and home fragrance retailer.
